This analysis reveals the difficulties in evaluating PCSK9 treatment timing after myocardial infarction, suggesting a need for better methods.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cars et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: